NCT01894984 An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia Status TERMINATED Phase N/A
NCT01892384 Safety and Tolerability of BI 409306 in Patients With Schizophrenia Status COMPLETED Phase PHASE1
NCT01891721 Evaluating Two Types of Cognitive Training in Veterans With Schizophrenia Status COMPLETED Phase NA
NCT01888627 Integrated Care in Psychotic Disorders With Severe Mental Illness Status RECRUITING Phase NA
NCT01888107 Maintenance of Efficacy With Risperidone Long Acting Injectable (R-LAI) in Patients With Schizophrenia or Schizoaffective Disorder Status COMPLETED Phase PHASE3
NCT01885338 N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in Schizophrenia Status COMPLETED Phase PHASE1
NCT01879722 Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizophrenia and Healthy Participants Status COMPLETED Phase PHASE1
NCT01878513 Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis Status COMPLETED Phase NA
NCT01876524 tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients Status COMPLETED Phase NA
NCT01876056 Brief Culturally Adapted Cognitive Behavior Therapy for Psychosis Status COMPLETED Phase NA
NCT01875822 Open-label Study of Curcumin C-3 Complex in Schizophrenia Status COMPLETED Phase PHASE1/PHASE2
NCT01874756 The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia Status TERMINATED Phase PHASE2
NCT01870999 A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot Status COMPLETED Phase PHASE1
NCT01869660 Shared Decision Making for Patients With First-admission Schizophrenia Status COMPLETED Phase PHASE2/PHASE3